Omeros (OMER) Revenue (2010 - 2026)

Omeros (OMER) posted Revenue of $9.9 million for Q1 2026, down 2.07% sequentially from $10.1 million in Q2 2022.

Omeros (OMER) Revenue (2010 - 2026) Analysis & Trends

Omeros has reported Revenue for 14 years, with the latest figure at $9.9 million in Q1 2026.

Quarterly Revenue changed N/A year-over-year to $9.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.0 million (up 142.99% YoY) and the FY2020 annual result came in at $73.8 million, down 33.98% from the prior year.
Revenue eased to $9.9 million in Q1 2026 per OMER's latest filing, from $10.1 million in the prior quarter.
Over five years, Revenue peaked at $10.1 million in Q2 2022 and troughed at $7.0 million in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	3.33 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	4.29 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	1.56 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	1.71 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	3,001.92
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	674.14 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	1.29 Bn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	425.49 Mn
10	Omeros	1.24 Bn	1.24 Bn	27.73 Mn	28.53 Mn

Download Data